drugset / Trial / NCT06128733
Study of an Investigational Pentavalent Meningococcal ABCYW Vaccine in Adults and Adolescents
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of VAN00010 study is to assess the safety and immunogenicity of the investigational pentavalent meningococcal ABCYW vaccine in adults and adolescents. The study duration will be up to 12 months for all participants.
Timeline
- Start
- 2023-10-31
- Primary completion
- 2025-08-27
- Completion
- 2025-08-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bexsero | Vaccine | — | Intramuscular |
| Subject | MenACYW conjugate vaccine | Vaccine | — | Intramuscular |
| Subject | Menveo | Vaccine | — | Intramuscular |
| Subject | PENBRAYATM | Unknown | — | Intramuscular |
| Subject | Pentavalent Meningococcal ABCYW vaccine | Vaccine | — | Intramuscular |
| Subject | Trumenba | Vaccine | — | Intramuscular |